UK markets open in 30 minutes

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7400+0.0900 (+3.40%)
At close: 04:00PM EDT
2.7800 +0.04 (+1.46%)
After hours: 04:19PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
9,432
19,993
32,948
7,143
-
Other short-term investments
0
433
904
675
-
Total cash
9,432
20,426
33,852
7,818
-
Net receivables
484
2,012
1,437
203
-
Inventory
-
-
304
0
-
Other current assets
643
977
901
295
-
Total current assets
10,698
25,536
39,143
9,226
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,436
10,851
8,369
7,964
-
Accumulated depreciation
-
-
-2,715
-1,440
-343
Net property, plant and equipment
5,436
10,851
8,369
6,524
-
Equity and other investments
-
-
0
13,417
10,964
Goodwill
-
0
18,684
9,187
0
Intangible assets
56,595
61,633
61,721
15,009
-
Other long-term assets
2,163
2,071
31,646
2,056
-
Total non-current assets
64,194
74,555
120,420
46,193
-
Total assets
74,892
100,091
159,563
55,419
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
1,313
2,390
1,125
Accounts payable
953
1,253
1,810
432
-
Accrued liabilities
1,568
3,948
3,473
2,284
-
Other current liabilities
45
2,005
1,526
600
-
Total current liabilities
7,194
12,106
14,120
8,996
-
Non-current liabilities
Long-term debt
-
-
-
1,508
1,905
Other long-term liabilities
39,900
45,662
76,681
7,120
-
Total non-current liabilities
47,230
53,693
80,226
12,940
-
Total liabilities
54,424
65,799
94,346
21,936
-
Stockholders' equity
Common stock
310,295
294,929
252,954
157,160
-
Retained earnings
-289,876
-260,676
-187,774
-123,677
-
Accumulated other comprehensive income
49
39
37
0
-
Total stockholders' equity
20,468
34,292
65,217
33,483
-
Total liabilities and stockholders' equity
74,892
100,091
159,563
55,419
-